LISAvienna Newsletter: Review of recent news items

Subscribe to our newsletter to stay up-to-date! Today’s edition includes news items from AFFiRiS, allcyte, APEIRON Biologics, Apeptico, BlueSky, Cebina, contextflow, Cubicure, Delta4, Eveliqure, F2G, Hookipa Pharma, LEAD Horizon, Marinomed, Medbee,, myBioma, Nabriva, PhagoMed, Themis Bioscience, UpNano, Valneva and the Vienna BioCenter.

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)